Monday, August 31, 2026

Gevo Stock Bearish By 27% In The Last 21 Sessions

Gevo Stock Bearish By 27% In The Last 21 Sessions

(VIANEWS) - Shares of Gevo (NASDAQ: GEVO) fell by a staggering 27.06% in 21 sessions from $1.7 at 2023-03-15, to $1.24 at 12:37 EST on Friday, following the last session's upward trend. NASDAQ is falling 0.86% to $12,062.02, following the last session's upward trend.

Gevo's last close was $1.26, 75.95% under its 52-week high of $5.24.

About Gevo

Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.

Earnings Per Share

As for profitability, Gevo has a trailing twelve months EPS of $-0.46.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -15.05%.

Volatility

Gevo's last week, last month's, and last quarter's current intraday variation average was a negative 0.26%, a negative 1.83%, and a positive 3.57%.

Gevo's highest amplitude of average volatility was 3.01% (last week), 4.17% (last month), and 3.57% (last quarter).

Sales Growth

Gevo's sales growth is 3455.6% for the present quarter and 1770.7% for the next.

Moving Average

Gevo's worth is way under its 50-day moving average of $1.88 and way below its 200-day moving average of $2.28.

Growth Estimates Quarters

The company's growth estimates for the current quarter and the next is 25% and 50%, respectively.

More news about Gevo (GEVO).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com